TrialNature communications2023
Randomized, double-blind, placebo-controlled trial of rapamycin in amyotrophic lateral sclerosis.
Jessica Mandrioli et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
58 papers cite it
this paperpooled ittrialcites it